Document Detail

A chemiluminescent immunoassay for 17 alpha-methyltestosterone.
MedLine Citation:
PMID:  4018314     Owner:  NLM     Status:  MEDLINE    
An immunoassay for the xenobiotic anabolic compound methyltestosterone (MT) is presented. The detection is based on chemiluminescence of a MT-isoluminol conjugate. Applications are presented for detection of methyltestosterone and cross-reacting compounds in bovine urine and tissues of application sites isolated from slaughtered cattle, illegally treated with hormonal anabolics.
E H Jansen; R H Van den Berg; G Zomer; R W Stephany
Related Documents :
15345314 - Chemiluminescent immunosensor for ca19-9 based on antigen immobilization on a cross-lin...
6537354 - Synthesis of three n-nitroso dipeptides n-terminal in proline and a method for their de...
24779874 - T-2 and ht-2 toxins in cereals and cereal-based products in south korea.
1955074 - Endothelin-1 in luteal tissue.
10222354 - Comparison of three different plasma homocysteine assays with gas chromatography-mass s...
22749584 - Simultaneous determination of cork taint and brett character responsible compounds in w...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Food additives and contaminants     Volume:  2     ISSN:  0265-203X     ISO Abbreviation:  Food Addit Contam     Publication Date:    1985 Jan-Mar
Date Detail:
Created Date:  1985-08-30     Completed Date:  1985-08-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8500474     Medline TA:  Food Addit Contam     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  47-53     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cross Reactions
Immunoassay / methods
Luminescent Measurements
Methyltestosterone / urine*
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Determination of synthetic growth promoters in bile.
Next Document:  Sulphiting agents in foods: some risk/benefit considerations.